162 related articles for article (PubMed ID: 37116587)
21. Integrated view on 17beta-hydroxysteroid dehydrogenases.
Moeller G; Adamski J
Mol Cell Endocrinol; 2009 Mar; 301(1-2):7-19. PubMed ID: 19027824
[TBL] [Abstract][Full Text] [Related]
22. Unusual evolution of 11beta- and 17beta-hydroxysteroid and retinol dehydrogenases.
Baker ME
Bioessays; 1996 Jan; 18(1):63-70. PubMed ID: 8593166
[TBL] [Abstract][Full Text] [Related]
23. Cloning and expression of cDNA encoding hamster liver 3-hydroxyhexobarbital/17beta(3alpha)-hydroxysteroid dehydrogenase 1.
Takenoshita R; Nomura Y; Toki S
Chem Biol Interact; 2001 Jan; 130-132(1-3):863-70. PubMed ID: 11306101
[TBL] [Abstract][Full Text] [Related]
24. Subcellular localization and membrane topology of 17β-hydroxysteroid dehydrogenases.
Tsachaki M; Odermatt A
Mol Cell Endocrinol; 2019 Jun; 489():98-106. PubMed ID: 30864548
[TBL] [Abstract][Full Text] [Related]
25. NAFLD and renal function in children: is there a genetic link?
Di Sessa A; Guarino S; Passaro AP; Liguori L; Umano GR; Cirillo G; Miraglia Del Giudice E; Marzuillo P
Expert Rev Gastroenterol Hepatol; 2021 Sep; 15(9):975-984. PubMed ID: 33851883
[No Abstract] [Full Text] [Related]
26. Multifunctionality of human 17beta-hydroxysteroid dehydrogenases.
Moeller G; Adamski J
Mol Cell Endocrinol; 2006 Mar; 248(1-2):47-55. PubMed ID: 16413960
[TBL] [Abstract][Full Text] [Related]
27. Loss of immunity-related GTPase GM4951 leads to nonalcoholic fatty liver disease without obesity.
Zhang Z; Xun Y; Rong S; Yan L; SoRelle JA; Li X; Tang M; Keller K; Ludwig S; Moresco EMY; Beutler B
Nat Commun; 2022 Jul; 13(1):4136. PubMed ID: 35842425
[TBL] [Abstract][Full Text] [Related]
28. Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5.
Lin SX; Shi R; Qiu W; Azzi A; Zhu DW; Dabbagh HA; Zhou M
Mol Cell Endocrinol; 2006 Mar; 248(1-2):38-46. PubMed ID: 16480815
[TBL] [Abstract][Full Text] [Related]
29. Liver X receptor α induces 17β-hydroxysteroid dehydrogenase-13 expression through SREBP-1c.
Su W; Peng J; Li S; Dai YB; Wang CJ; Xu H; Gao M; Ruan XZ; Gustafsson JÅ; Guan YF; Zhang XY
Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E357-E367. PubMed ID: 28270440
[TBL] [Abstract][Full Text] [Related]
30. Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis.
Tang S; Zhang J; Mei TT; Zhang WY; Zheng SJ; Yu HB
BMC Gastroenterol; 2021 Dec; 21(1):490. PubMed ID: 34930143
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.
Fang Z; Dou G; Wang L
Int J Biol Sci; 2021; 17(7):1851-1863. PubMed ID: 33994867
[TBL] [Abstract][Full Text] [Related]
32. Pediatric non-alcoholic fatty liver disease and kidney function: Effect of
Di Sessa A; Umano GR; Cirillo G; Passaro AP; Verde V; Cozzolino D; Guarino S; Marzuillo P; Miraglia Del Giudice E
World J Gastroenterol; 2020 Sep; 26(36):5474-5483. PubMed ID: 33024398
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of
Luukkonen PK; Sakuma I; Gaspar RC; Mooring M; Nasiri A; Kahn M; Zhang XM; Zhang D; Sammalkorpi H; Penttilä AK; Orho-Melander M; Arola J; Juuti A; Zhang X; Yimlamai D; Yki-Järvinen H; Petersen KF; Shulman GI
Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2217543120. PubMed ID: 36669104
[TBL] [Abstract][Full Text] [Related]
34. The Effect of Genetic Polymorphism in Response to Body Weight Reduction in Japanese Patients with Nonalcoholic Fatty Liver Disease.
Seko Y; Yamaguchi K; Tochiki N; Yano K; Takahashi A; Okishio S; Kataoka S; Okuda K; Umemura A; Moriguchi M; Itoh Y
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33922278
[TBL] [Abstract][Full Text] [Related]
35. Characterization of essential domains in HSD17B13 for cellular localization and enzymatic activity.
Ma Y; Karki S; Brown PM; Lin DD; Podszun MC; Zhou W; Belyaeva OV; Kedishvili NY; Rotman Y
J Lipid Res; 2020 Nov; 61(11):1400-1409. PubMed ID: 32973038
[TBL] [Abstract][Full Text] [Related]
36. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase.
Yang SY; He XY; Schulz H
Trends Endocrinol Metab; 2005; 16(4):167-75. PubMed ID: 15860413
[TBL] [Abstract][Full Text] [Related]
37. Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective.
Ching-Yeung Yu B; Kwok D; Wong VW
J Clin Exp Hepatol; 2019; 9(4):491-496. PubMed ID: 31516265
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning of a novel type of rat cytoplasmic 17beta-hydroxysteroid dehydrogenase distinct from the type 5 isozyme.
Ishikura S; Matsumoto K; Sanai M; Horie K; Matsunaga T; Tajima K; El-Kabbani O; Hara A
J Biochem; 2006 Jun; 139(6):1053-63. PubMed ID: 16788056
[TBL] [Abstract][Full Text] [Related]
39. Perspectives in understanding the role of human 17beta-hydroxysteroid dehydrogenases in health and disease.
Meier M; Möller G; Adamski J
Ann N Y Acad Sci; 2009 Feb; 1155():15-24. PubMed ID: 19250188
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort
Anstee QM; Darlay R; Cockell S; Meroni M; Govaere O; Tiniakos D; Burt AD; Bedossa P; Palmer J; Liu YL; Aithal GP; Allison M; Yki-Järvinen H; Vacca M; Dufour JF; Invernizzi P; Prati D; Ekstedt M; Kechagias S; Francque S; Petta S; Bugianesi E; Clement K; Ratziu V; Schattenberg JM; Valenti L; Day CP; Cordell HJ; Daly AK;
J Hepatol; 2020 Sep; 73(3):505-515. PubMed ID: 32298765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
